The DNDi podcast

'Leishmaniasis is not only a disease of the skin but also of inequity, climate, and opportunity.’ Tune in to our in-depth conversation with Dr Mawatheeq Al-Yafrosi, a dermatology resident at Al-Thawra Modern General Hospital in Sana’a, Yemen. Many of Dr Al-Yafrosi’s patients are affected by cutaneous leishmaniasis, a neglected parasitic disease that can lead to acute social stigma, particularl...

'The color of a tablet seems like a trivial thing, but it is not.' Tune in to our in-depth conversation with Dr Stephen Robinson, Pharmaceutical Development Director at DNDi. Stephen oversees all Chemistry, Manufacturing and Control (CMC) work for both DNDi and our sister organization GARDP. In this interview, he talks in particular about zoliflodacin, a newly registered antibiotic for gon...

'Any organization that works in R&D has a duty to have proper governance that includes peer review .’ Tune in to our in-depth interview conversation with Dr Pauline Williams, the newly appointed chair of DNDi's Scientific Advisory Committee (SAC).  Dr Williams explains why SAC's scientific opinions are so important to DNDi’s work. She shares her views on non-profit medical R&D ...